financetom
Business
financetom
/
Business
/
China's Pony AI Expands Paid Robotaxi Services in Guangzhou; Shares Jump Premarket
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
China's Pony AI Expands Paid Robotaxi Services in Guangzhou; Shares Jump Premarket
Feb 21, 2025 2:38 AM

05:22 AM EST, 02/21/2025 (MT Newswires) -- Pony AI (PONY), an autonomous mobility company, said early Friday that it introduced paid robotaxi services from multiple locations in Guangzhou's city center to Guangzhou Baiyun International Airport and Guangzhou South Railway Station in China.

Shares of the company traded 5.5% higher in premarket activity.

The move comes after Pony.ai introduced paid robotaxi rides to and from Beijing Daxing International Airport and to and from Beijing South Railway Station.

Price: 18.87, Change: +0.99, Percent Change: +5.54

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ride-hailing platform Lyft ties up with Anthropic for AI-powered customer care
Ride-hailing platform Lyft ties up with Anthropic for AI-powered customer care
Feb 6, 2025
(Reuters) - Lyft ( LYFT ) said on Thursday it has tied up with Amazon ( AMZN ) and Alphabet-backed startup Anthropic to roll out artificial intelligence tools for the ride-hailing platform's customer care operations. The company said it has been using Anthropic's Claude AI model, through Amazon's ( AMZN ) Bedrock generative AI platform, which has helped reduce the...
Merck Initiates Phase 3 Trial of Zilovertamab Vedotin Antibody-Drug Conjugate to Treat Lymphoma
Merck Initiates Phase 3 Trial of Zilovertamab Vedotin Antibody-Drug Conjugate to Treat Lymphoma
Feb 6, 2025
09:04 AM EST, 02/06/2025 (MT Newswires) -- Merck ( MRK ) said Thursday that it has initiated a pivotal phase 3 clinical trial evaluating zilovertamab vedotin, an investigational antibody-drug conjugate to treat patients with previously untreated diffuse large B-cell lymphoma. The company said the trial will combine zilovertamab vedotin with rituximab plus cyclophosphamide, doxorubicin and prednisone, compared with rituximab plus...
InterDigital's Q4 Adjusted Earnings, Revenue Rise; Provides 2025 Guidance
InterDigital's Q4 Adjusted Earnings, Revenue Rise; Provides 2025 Guidance
Feb 6, 2025
09:06 AM EST, 02/06/2025 (MT Newswires) -- InterDigital (IDCC) reported Q4 adjusted earnings Thursday of $5.15 per diluted share, up from $1.41 a year earlier. Analysts polled by FactSet expected $4.98. Revenue for the quarter ended Dec. 31 was $252.8 million compared with $105.5 million a year earlier. Analysts surveyed by FactSet expected $244.2 million. For Q1, the company expects...
Sonos Fiscal Q1 Non-GAAP Net Income, Revenue Decrease
Sonos Fiscal Q1 Non-GAAP Net Income, Revenue Decrease
Feb 6, 2025
09:04 AM EST, 02/06/2025 (MT Newswires) -- Sonos ( SONO ) reported fiscal Q1 non-GAAP net income Thursday of $0.64 per diluted share, down from $0.84 a year earlier. Three analysts polled by FactSet expected $0.30. Revenue for the fiscal quarter ended Dec. 28 was $550.9 million, down from $612.9 million a year earlier. Analysts surveyed by FactSet expected $519.8...
Copyright 2023-2026 - www.financetom.com All Rights Reserved